<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1885">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05136625</url>
  </required_header>
  <id_info>
    <org_study_id>553/2021/Sper/AOUFe</org_study_id>
    <nct_id>NCT05136625</nct_id>
  </id_info>
  <brief_title>Sphenopalatine Ganglion Block and Pain Management in Neurosurgery</brief_title>
  <acronym>SpheNoPain</acronym>
  <official_title>Sphenopalatine Ganglion Block and Pain Management in Neurosurgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Ferrara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post craniotomy pain is defined as headache developed up to 7 days from a craniotomy, not&#xD;
      otherwise explained. A moderate to severe pain affects from 60 to 84% of patients.&#xD;
&#xD;
      Sphenopalatine ganglion block has been successfully used in patients with chronic or acute&#xD;
      headache, facial pain and for transsphenoidal pituitary and endoscopic sinus surgeries.&#xD;
&#xD;
      There are evidences that sphenopalatine ganglion block reduces vegetative responses to skull&#xD;
      pin closure.&#xD;
&#xD;
      This study aim to investigate feasibility and efficacy of sphenopalatine ganglion block in&#xD;
      reducing pain after a neurosurgical supratentorial craniotomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>Immediately post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>1° days post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>2° days post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>3° days post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>4° days post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>30° days post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>60° days post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>180° days post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>Immediately post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>1° day post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever) on a straight line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>2° day post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever) on a straight line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>3° day post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever) on a straight line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>4° day post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever) on a straight line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>30° day post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever) on a straight line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>60° day post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever) on a straight line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogic Scale</measure>
    <time_frame>180° day post-op</time_frame>
    <description>From 0 (no pain) to 10 (worst pain ever) on a straight line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>Immediately post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>1° day post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>2° day post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>3° day post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>4° day post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>30° day post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>60° day post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Assessment IN Advanced Dementia</measure>
    <time_frame>180° day post-op</time_frame>
    <description>From 0 (no signs of pain) to 10 (Extreme pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse effect</measure>
    <time_frame>Immediately post-op, 1°-2°-3°-4°-30°-60°180° days post-op</time_frame>
    <description>Bitter taste, nose bleeding, throat discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vegetative response (Heart rate)</measure>
    <time_frame>1-5-10 min from skull pin closure. 1-5-10 min from skin incision</time_frame>
    <description>Heart rate in beat per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vegetative response (Arterial pressure)</measure>
    <time_frame>1-5-10 min from skull pin closure. 1-5-10 min from skin incision</time_frame>
    <description>Mean arterial pressure in mmHg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Post Operative Pain</condition>
  <condition>Craniofacial Pain</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Troncular scalp blockade (Levobupivacaine 7,5%) Local site infiltration (Mepivacaine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Troncular scalp blockade (Levobupivacaine 7,5%) Local site infiltration (Mepivacaine) Transnasal sphenopalatine ganglion block (Levobupivacaine 7,5%)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sphenopalatine ganglion block</intervention_name>
    <description>A cotton swab soaked in levobupivacaine 7,5% in inserted into the nose to block sphenopalatine ganglion, with the classic technique previously described</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard Preparation</intervention_name>
    <description>Troncular scalp blockade. Local site infiltration</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  supratentorial craniotomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  prior craniofacial pain syndrome&#xD;
&#xD;
          -  drug assumption: pain-killers (chronic), antiepileptic&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pasquale De Bonis, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Università degli Studi di Ferrara</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alba Scerrati, MD</last_name>
    <phone>3381402733</phone>
    <email>scrlba@unife.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giorgio Mantovani, MD</last_name>
    <phone>3491974608</phone>
    <email>mntgrg@unife.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sant'Anna Hospital</name>
      <address>
        <city>Ferrara</city>
        <state>Emilia Romagna</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alba Scerrati, MD</last_name>
      <phone>3381402733</phone>
      <email>scrlba@unife.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Sir E, Eksert S. Morphological Description and Clinical Implication of Sphenopalatine Foramen for Accurate Transnasal Sphenopalatine Ganglion Block: An Anatomical Study. Medeni Med J. 2019;34(3):239-243. doi: 10.5222/MMJ.2019.20586. Epub 2019 Sep 27.</citation>
    <PMID>32821444</PMID>
  </reference>
  <reference>
    <citation>Padhy N, Moningi S, Kulkarni DK, Alugolu R, Inturi S, Ramachandran G. Sphenopalatine ganglion block: Intranasal transmucosal approach for anterior scalp blockade - A prospective randomized comparative study. J Anaesthesiol Clin Pharmacol. 2020 Apr-Jun;36(2):207-212. doi: 10.4103/joacp.JOACP_249_18. Epub 2020 Jun 15.</citation>
    <PMID>33013036</PMID>
  </reference>
  <reference>
    <citation>Crespi J, Bratbak D, Dodick D, Matharu M, Jamtøy KA, Aschehoug I, Tronvik E. Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study. J Headache Pain. 2018 Feb 13;19(1):14. doi: 10.1186/s10194-018-0843-5.</citation>
    <PMID>29442191</PMID>
  </reference>
  <reference>
    <citation>Elahi F, Ho KW. Successful Management of Refractory Headache and Facial Pain due to Cavernous Sinus Meningioma with Sphenopalatine Ganglion Radiofrequency. Case Rep Neurol Med. 2014;2014:923516. doi: 10.1155/2014/923516. Epub 2014 Sep 29.</citation>
    <PMID>25343051</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sphenopalatine ganglion block</keyword>
  <keyword>post-craniotomy pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganglion Cysts</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

